Skip to main
XAIR

XAIR Stock Forecast & Price Target

XAIR Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Beyond Air Inc. demonstrated robust financial performance in the quarter ended June 30, 2025, with revenue increasing by 157% to $1.8 million, driven by strong demand for its LungFit PH system across domestic and international markets. The company achieved a milestone with positive gross profit of $0.2 million, a significant recovery from a gross loss of $0.3 million in the prior year, highlighting a turnaround in its growth trajectory. Additionally, the strategic national group purchasing agreement with Premier, Inc. enhances access to Beyond Air's innovative technology across over 4,350 hospitals and health systems, potentially fostering accelerated commercial adoption and broader market penetration.

Bears say

Beyond Air Inc. reported a net loss of $7.9 million for the latest period, indicating ongoing financial challenges despite a reduction in gross loss and operating expenses compared to the previous year. The company’s research and development expenses decreased substantially to $2.5 million, but the net cash burn of $4.7 million raises concerns about its financial sustainability. Additionally, the potential adverse effects of Nitric Oxide on cellular respiration within the tumor microenvironment may complicate the development of its therapies, further contributing to a negative outlook on the stock.

XAIR has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Beyond Air Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Beyond Air Inc (XAIR) Forecast

Analysts have given XAIR a Strong Buy based on their latest research and market trends.

According to 1 analysts, XAIR has a Strong Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Beyond Air Inc (XAIR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.